Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.

Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...

Leerink Partnrs downgraded shares of 10x Genomics (NASDAQ:TXG – Free Report) from a strong-buy rating to a hold rating in a ...

10x Genomics, Inc., a life science technology company ... the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

The NIH projected the cut will save it $4 billion during the current federal fiscal year, which ends September 30. That’s ...